DEC 26, 2017 11:44 AM PST

Nanoparticles Improve Chemotherapy Via Anti-tumor Immunity

WRITTEN BY: Courtney Schaal

Doxorubicin, tradename Adriamycin, is a well known chemotherapeutic agent used to treat a variety of cancer types including lymphoma, leukemia, myeloma, breast, stomach, lung, thyroid, and bladder cancer, and Kaposi’s sarcoma. It is typically administered by intravenous or iv injection, and is associated with unpleasant toxicities and side effects. It was first approved for use in the United States in 1974, so it is safe to say it has been around for quite some time now. Doxorubicin works by intercalating into DNA, thereby preventing DNA replication progression and cell division, ultimately leading to cell death. This is great for killing of cancer cells, but it is not selective and hits healthy, non-cancerous cells as well.

The lab of Dr. Ashutosh Chilkoti at Duke University in North Carolina has recently shown that nanoparticle formulation can improve the efficacy of doxorubicin through increase in anti-tumor immune response, and the results of this study are set to be published in January (2018) in the Journal of Controlled Release. Nanoparticles themselves have been a topic of interest for therapeutics of late, and harnessing anti-tumor immune response has proven an effective hot area of study for cancer treatment over the past several years. In the above mentioned study, they utilize both approaches in an effort to improve cancer therapy. 

Doxorubicin can contribute to establishing anti-tumor immunity through enhancing immune-mediated cell death. Dr. Chilkoti’s group show that use of a nanoparticle formulation of doxorubicin which they call CP-Dox (short for Chimeric Polypeptide Doxorubicin), can enhance such antitumor immunity. They compare traditional “free” doxorubicin to a single, iv injection of CP-Dox at the maximum tolerated dose into tumors in mice, and find there is a resulting increase in the number of infiltrating leukocytes and subsequent decrease in tumor growth and metastasis. They go on to show that these results are dependent upon CD8 positive T-cells, otherwise known as the “killer” T-cells, as well as interferon-gamma. The treatment was also found to impact myeloid cell polarization within the tumor itself toward an anti-tumor phenotype. Overall this shows the efficacy of a nanoparticle-based chemotherapeutic (that is doxorubicin) and its ability to elicit anti-tumor immunity, in a manner distinct from the traditional “free” chemotherapy. The authors conclude that this study “strongly argues for the use of anti-tumor immunotherapies combined with nanoparticle-packaged chemotherapy” to combat cancer more effectively.

Sources: Journal of Controlled Release, Wikipedia, Pixabay

About the Author
You May Also Like
MAY 04, 2021
Health & Medicine
Micro-dosing Inhaler Breakthrough for Medical Cannabis
MAY 04, 2021
Micro-dosing Inhaler Breakthrough for Medical Cannabis
In a leap that will eliminate the risks of vaping or smoking, Canada has just approved an Israeli-made inhaler that is a ...
MAY 14, 2021
Health & Medicine
A National Standard THC Dose for Researchers is Here
MAY 14, 2021
A National Standard THC Dose for Researchers is Here
    Whatever your stance on cannabis, almost  everyone would agree that more, better quality, research sh ...
JUN 14, 2021
Microbiology
Researchers Identify a Novel, Beneficial Bacterium
JUN 14, 2021
Researchers Identify a Novel, Beneficial Bacterium
Since researchers were able to use genetic technologies to reveal how important the gut microbiome is to human health, t ...
JUN 28, 2021
Microbiology
Small Clinical Trial Suggests New Edible Cholera Vaccine Is Safe
JUN 28, 2021
Small Clinical Trial Suggests New Edible Cholera Vaccine Is Safe
According to WHO there have been six cholera pandemics since the pathogen emerged from the Ganges river delta sometime i ...
JUL 06, 2021
Immunology
New Nanotechnology Delivers RNA Drugs Only to "Bad" Immune Cells
JUL 06, 2021
New Nanotechnology Delivers RNA Drugs Only to "Bad" Immune Cells
Inflammatory conditions are linked to an overactive immune system, and resolving them therapeutically often involves cal ...
JUL 21, 2021
Drug Discovery & Development
A diet rich in phytoestrogens can help combat inflammation in multiple sclerosis.
JUL 21, 2021
A diet rich in phytoestrogens can help combat inflammation in multiple sclerosis.
Close to one million people in the United States are living with multiple sclerosis (MS). MS is a chronic, neuroinflamma ...
Loading Comments...